Xylosyltransferase engineering to manipulate proteoglycans in mammalian cells
More about Open Access at the CrickAuthors list
Zhen Li Himanshi Chawla Lucia Di Vagno Aisling Ní Cheallaigh Meg Critcher Douglas Sammon Edgar Gonzalez-Rodriguez David Briggs Nara Chung Vincent Chang Keira E Mahoney Anna Cioce Ganka Bineva-Todd Pei-Ying Wang Yi-Chang Liu Lloyd D Murphy Yen-Hsi Chen Yoshiki Narimatsu Rebecca L Miller Lianne I Willems Stacy A Malaker Mia L Huang Gavin J Miller Erhard Hohenester Ben SchumannAbstract
Mammalian cells receive signaling instructions through interactions on their surfaces. Proteoglycans are critical to these interactions, carrying long glycosaminoglycans that recruit signaling molecules. Biosynthetic redundancy in the first glycosylation step by two xylosyltransferases XT1/2 complicates annotation of proteoglycans. Here we develop a chemical genetic strategy that manipulates the glycan attachment site of cellular proteoglycans. Through a bump-and-hole tactic, we engineer the two isoenzymes XT1 and XT2 to specifically transfer the chemically tagged xylose analog 6AzGlc to target proteins. The tag contains a bioorthogonal functionality, allowing to visualize and profile target proteins in mammalian cells. Unlike xylose analogs, 6AzGlc is amenable to cellular nucleotide-sugar biosynthesis, establishing the XT1/2 bump-and-hole tactic in cells. The approach allows pinpointing glycosylation sites by mass spectrometry and exploiting the chemical handle to manufacture proteoglycans with defined glycosaminoglycan chains for cellular applications. Engineered XT enzymes permit an orthogonal view into proteoglycan biology through conventional techniques in biochemistry.
Journal details
Journal
Nature Chemical Biology
Pages
Epub ahead of print
Available online
Publication date
Full text links
Publisher website (DOI)
10.1038/s41589-025-02113-w
Europe PubMed Central
41559400
Pubmed
41559400
Keywords
Related topics
Type of publication
Publishing history
The publication was previously a preprint.
View preprint
